Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 2 cell differentiation. [GOC:go_curators]
Negative regulation of T-helper 2 cell differentiation is a complex process that involves a delicate balance of signaling pathways and transcription factors. It ensures proper immune system function by preventing excessive inflammation and allergic responses. Here's a detailed breakdown:
1. **Cytokine Signaling:** The differentiation of naive T cells into T helper 2 (Th2) cells is primarily driven by the cytokine interleukin-4 (IL-4). Negative regulation involves counteracting the effects of IL-4 and promoting the differentiation of other T helper subsets (like Th1 or Treg cells). This can be achieved through:
* **IL-4 receptor antagonists:** These molecules block IL-4 from binding to its receptor, preventing downstream signaling.
* **IL-4 antagonists:** These molecules directly inhibit the activity of IL-4, reducing its ability to stimulate Th2 differentiation.
* **Induction of other cytokines:** The production of cytokines like interferon-gamma (IFN-γ) or IL-12 can suppress Th2 differentiation by promoting the development of Th1 cells.
2. **Transcription Factor Regulation:** Transcription factors play a critical role in controlling gene expression during Th2 cell differentiation. Key negative regulators include:
* **GATA-3:** While GATA-3 is a key transcription factor for Th2 differentiation, its expression can be negatively regulated by other transcription factors.
* **STAT3:** This transcription factor is activated by IL-6 and IL-10, which can suppress Th2 differentiation.
* **Foxp3:** This transcription factor is essential for the development of regulatory T cells (Treg), which can suppress Th2 responses.
3. **Immune Checkpoint Regulation:** Immune checkpoints are molecules that regulate T cell activity. Negative regulation can occur through:
* **CTLA-4:** This checkpoint molecule inhibits T cell activation and proliferation, suppressing Th2 responses.
* **PD-1:** This checkpoint molecule can also suppress T cell activation and promote exhaustion, potentially limiting Th2 responses.
4. **Epigenetic Modifications:** Changes in chromatin structure and DNA methylation can regulate gene expression and influence Th2 cell differentiation. Negative regulation can involve:
* **Histone modifications:** Modifications like histone deacetylation can repress the expression of Th2-promoting genes.
* **DNA methylation:** Methylation of DNA can silence genes involved in Th2 differentiation.
These various mechanisms act in concert to ensure that the immune system maintains a balanced response to diverse stimuli, preventing excessive inflammation and promoting immune tolerance. Negative regulation of Th2 differentiation is essential for preventing allergic diseases, parasitic infections, and autoimmune disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
B-cell lymphoma 6 protein | A B-cell lymphoma 6 protein that is encoded in the genome of human. [PRO:CNA, UniProtKB:P41182] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
amanozine | diamino-1,3,5-triazine | ||
rifamycin sv | rifamycin SV : A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. rifamycin SV: RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009 | acetate ester; cyclic ketal; lactam; macrocycle; organic heterotetracyclic compound; polyphenol; rifamycins | antimicrobial agent; antitubercular agent; bacterial metabolite |
pf-562,271 | indoles |